BNP Paribas Asset Management
BSX icon

BNP Paribas Asset Management’s Boston Scientific BSX Stock Holding History

BNP Paribas Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$437M Sell
6,966,229
-756,851
-10% -$60.5M 0.51% 27
2025
Q4 		$736M Buy
7,723,080
+3,292,955
+74% +$323M 0.84% 14
2025
Q3 		$432M Buy
4,430,125
+218,465
+5% +$22.6M 1.12% 12
2025
Q2 		$452M Buy
4,211,660
+3,172
+0.1% +$321K 1.1% 10
2025
Q1 		$424M Sell
4,208,488
-47,065
-1% -$4.74M 1.14% 10
2024
Q4 		$380M Buy
4,255,553
+136,154
+3% +$12M 0.94% 13
2024
Q3 		$345M Buy
4,119,399
+173,034
+4% +$13.6M 0.86% 17
2024
Q2 		$304M Sell
3,946,365
-75,438
-2% -$5.52M 0.79% 19
2024
Q1 		$275M Sell
4,021,803
-487,325
-11% -$31.3M 0.73% 21
2023
Q4 		$261M Sell
4,509,128
-90,805
-2% -$4.85M 0.73% 21
2023
Q3 		$243M Buy
4,599,933
+2,070,244
+82% +$109M 0.74% 20
2023
Q2 		$137M Buy
2,529,689
+23,136
+0.9% +$1.21M 0.42% 51
2023
Q1 		$125M Sell
2,506,553
-220,345
-8% -$10.4M 0.43% 46
2022
Q4 		$126M Sell
2,726,898
-250,606
-8% -$10.9M 0.45% 48
2022
Q3 		$115M Buy
2,977,504
+695,380
+30% +$27.9M 0.45% 46
2022
Q2 		$85.1M Buy
2,282,124
+73,513
+3% +$2.99M 0.32% 71
2022
Q1 		$97.8M Buy
2,208,611
+142,567
+7% +$6.18M 0.34% 60
2021
Q4 		$87.8M Buy
2,066,044
+475,392
+30% +$20M 0.29% 75
2021
Q3 		$69M Buy
1,590,652
+246,918
+18% +$10.9M 0.26% 89
2021
Q2 		$57.5M Buy
1,343,734
+262,500
+24% +$11M 0.2% 123
2021
Q1 		$41.8M Buy
1,081,234
+335,971
+45% +$12.7M 0.17% 141
2020
Q4 		$26.8M Sell
745,263
-309,011
-29% -$11.1M 0.12% 202
2020
Q3 		$40.3M Sell
1,054,274
-500,610
-32% -$19.3M 0.23% 112
2020
Q2 		$54.6M Buy
1,554,884
+294,287
+23% +$10.6M 0.37% 64
2020
Q1 		$41.1M Buy
1,260,597
+374,482
+42% +$14.6M 0.35% 69
2019
Q4 		$40.1M Sell
886,115
-460,118
-34% -$19.3M 0.27% 109
2019
Q3 		$54.8M Buy
1,346,233
+89,546
+7% +$3.79M 0.42% 52
2019
Q2 		$54M Sell
1,256,687
-216,540
-15% -$8.33M 0.44% 50
2019
Q1 		$56.5M Sell
1,473,227
-90,955
-6% -$3.47M 0.47% 39
2018
Q4 		$54.2M Buy
1,564,182
+79,294
+5% +$2.88M 0.5% 32
2018
Q3 		$57.2M Buy
1,484,888
+242,668
+20% +$8.48M 0.44% 44
2018
Q2 		$40.6M Sell
1,242,220
-457,766
-27% -$13.8M 0.34% 64
2018
Q1 		$46.4M Sell
1,699,986
-73,991
-4% -$2.01M 0.39% 51
2017
Q4 		$44M Sell
1,773,977
-388,809
-18% -$10.7M 0.37% 50
2017
Q3 		$63.1M Buy
2,162,786
+261,051
+14% +$7.21M 0.53% 32
2017
Q2 		$52.7M Sell
1,901,735
-467,063
-20% -$12.4M 0.47% 40
2017
Q1 		$58.9M Sell
2,368,798
-374,749
-14% -$9.11M 0.54% 34
2016
Q4 		$59.3M Buy
2,743,547
+408,776
+18% +$8.92M 0.57% 28
2016
Q3 		$55.6M Sell
2,334,771
-13,520
-0.6% -$323K 0.47% 38
2016
Q2 		$54.9M Buy
2,348,291
+586,919
+33% +$12.7M 0.46% 43
2016
Q1 		$33.1M Buy
1,761,372
+609,569
+53% +$10.7M 0.28% 86
2015
Q4 		$21.2M Sell
1,151,803
-36,983
-3% -$663K 0.18% 151
2015
Q3 		$19.5M Sell
1,188,786
-63,754
-5% -$1.09M 0.17% 169
2015
Q2 		$22.2M Buy
1,252,540
+1,151,626
+1,141% +$20.6M 0.18% 153
2015
Q1 		$1.79M Sell
100,914
-867,580
-90% -$13.7M 0.01% 744
2014
Q4 		$12.8M Buy
968,494
+937,354
+3,010% +$12M 0.1% 253
2014
Q3 		$368K Sell
31,140
-316,920
-91% -$3.99M ﹤0.01% 847
2014
Q2 		$4.44M Buy
348,060
+129,834
+59% +$1.69M 0.03% 492
2014
Q1 		$2.95M Buy
218,226
+169,562
+348% +$2.23M 0.02% 552
2013
Q4 		$585K Sell
48,664
-97,776
-67% -$1.16M ﹤0.01% 761
2013
Q3 		$1.72M Sell
146,440
-3,046,921
-95% -$33M 0.01% 624
2013
Q2 		$29.6M Buy
+3,193,361
New +$27.1M 0.22% 135

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Asset Management's BSX Position: Q1 2026 in Review

BNP Paribas Asset Management reduced its Boston Scientific (BSX) stake by 9.8% in Q1 2026, selling an estimated $60.5M and leaving 6,966,229 shares worth $437M. The position accounts for 0.51% of the portfolio, ranked #27.

BNP Paribas Asset Management first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $736M in Q4 2025. 1,672 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • BNP Paribas Asset Management held 6,966,229 shares of Boston Scientific worth $437M as of Q1 2026.
  • BNP Paribas Asset Management sold 756,851 Boston Scientific shares in Q1 2026, an estimated $60.5M.
  • Boston Scientific made up 0.51% of BNP Paribas Asset Management's portfolio in Q1 2026, its #27 holding.
  • BNP Paribas Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • BNP Paribas Asset Management's Boston Scientific position peaked at $736M in Q4 2025.
  • 1,672 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.